Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

    Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

    FromThe Lancet Diabetes & Endocrinology in conversation with

    Start listeningView podcast show

    Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

    FromThe Lancet Diabetes & Endocrinology in conversation with

    ratings:
    Length:
    10 minutes
    Released:
    Jul 19, 2022
    Format:
    Podcast episode

    Description

    Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.Read the full article:Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma
    Released:
    Jul 19, 2022
    Format:
    Podcast episode

    Titles in the series (48)

    Our Editors and and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.